Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 274 papers

Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure

Kerbert AJC, Gupta S, Alabsawy E, Dobler I, Lønsmann I, Hall A, Nielsen SH, Nielsen MJ, Gronbaek H, Amoros À, Yeung D, Macnaughtan J, Mookerjee RP, Macdonald S, Andreola F, Moreau R, Arroyo V, Angeli P, Leeming DJ, Treem W, Karsdal MA, Jalan R.

JHEP Rep 2021, 3(6): 100355

DOI: 10.1016/j.jhepr.2021.100355

Extrahepatic surgery in cirrhosis significantly increases portal pressure in preclinical animal models

Chang J, Meinke J, Geck M, Hebest M, Böhling N, Dolscheid-Pommerich R, Stoffel-Wagner B, Kristiansen G, Overhaus M, Peyman LO, Klein S, Uschner FE, Brol MJ, Vilz TO, Lingohr P, Kalff JC, Jansen C, Strassburg CP, Wehner S, Trebicka J, Praktiknjo M.

Front Physiol 2021, 12: 720898

DOI: 10.3389/fphys.2021.720898

The specific NLRP3 antagonist IFM-514 decreases fibrosis and inflammation in experimental murine non-alcoholic steatohepatitis

Torres S, Brol MJ, Magdaleno F, Schierwagen R, Uschner FE, Klein S, Ortiz C, Tyc O, Bachtler N, Stunden J, Bertheloot D, Kitanovic A, Sanchez B, Schrum J, Roush WR, Franchi L, Byth K, Latz E, Trebicka J.

Front Mol Biosci 2021, 8: 715765

DOI: 10.3389/fmolb.2021.715765

Impact of hepatic encephalopathy on clinical characteristics and adverse outcomes in prospective and multicenter cohorts of patients with acute-on-chronic liver diseases

Long L, Li H, Deng G, Wang X, Lu S, Li B, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Ren H, Shang J, Li H, Wang S, Zheng Y, Yan H, Yin S, Tan W, Zhang Q, Zheng X, Chen J, Luo S, Zhao J, Yuan W, Li T, Zheng R, Liu J, Liu X, Gu W, Li S, Mei X, Chen R, Huang Y.

Front Med 2021, 8: 709884

DOI: 10.3389/fmed.2021.709884

Acute-on-chronic liver failure: A distinct clinical syndrome

Moreau R, Gao B, Papp M, Bañares R, Kamath PS.

J Hepatol 2021, 75 Suppl 1: S27–S35

DOI: 10.1016/j.jhep.2020.11.047

Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation

Burra P, Samuel D, Sundaram V, Duvoux C, Petrowsky H, Terrault N, Jalan R.

J Hepatol 2021, 75 Suppl 1: S178–S190

DOI: 10.1016/j.jhep.2021.01.007

Management of bacterial and fungal infections in cirrhosis: The MDRO challenge

Fernández J, Piano S, Bartoletti M, Wey EQ.

J Hepatol 2021, 75 Suppl 1: S101–S117

DOI: 10.1016/j.jhep.2020.11.010

New clinical and pathophysiological perspectives defining the trajectory of cirrhosis

Jalan R, D'Amico G, Trebicka J, Moreau R, Angeli P, Arroyo V.

J Hepatol 2021, 75 Suppl 1: S14–S26

DOI: 10.1016/j.jhep.2021.01.018

Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction

Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M.

J Hepatol 2021, 75 Suppl 1(Suppl 1): S49–S66

DOI: 10.1016/j.jhep.2021.01.002

The microbiota in cirrhosis and its role in hepatic decompensation

Trebicka J, Macnaughtan J, Schnabl B, Shawcross DL, Bajaj JS.

J Hepatol 2021, 75 Suppl 1(Suppl 1): S67–S81

DOI: 10.1016/j.jhep.2020.11.013